Follica's Micro-Wounding Technique: How Skin Disruption Regrows Hair
Clinical Summary & Executive TakeawayFast Read
Evidence Grade
PMDA Regenerative Medicine Framework / Preclinical Primordia Data
Target Pathway
In Vitro Expanded Human Dermal Papilla Primordia and Vascularized Follicle Germs
Safety & Tolerance Note:
Cell manufacturing scalability and cellular senescence management.
Practical Patient Verdict:
Pioneering cellular multiplication that breaks the donor limitation barrier. Commercial availability is governed by Japan's expedited regenerative regulatory pathway.
Follica's innovative approach to hair loss treatment, which combines skin disruption with minoxidil application, has shown promising results in clinical trials, and its logic is rooted in a deeper understanding of how our skin and hair follicles interact. for patients managing long-term hair loss, I'm Evaluating the science behind this protocol and what it might mean for the future of hair restoration.
Sign in to like, save, or comment.
References & Clinical Data
- Platelet-rich plasma for androgenetic alopecia: a review , Giordano S, et al. (International Journal of Molecular Sciences, 2023)
- Hair follicle stem cells and their niche , Rompolas P, Greco V (Journal of Investigative Dermatology, 2014)
- JAK inhibitors in the treatment of alopecia areata , Craiglow BG, King BA (Journal of Investigative Dermatology, 2015)
- Wnt-dependent de novo hair follicle regeneration in adult mouse skin , Ito M, et al. (Nature, 2007)